ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Acetaminophen, Caffeine And Dihydrocodeine Bitartrate, and what generic alternatives are available?
Acetaminophen, Caffeine And Dihydrocodeine Bitartrate is a drug marketed by Larken Labs Inc and is included in one NDA.
The generic ingredient in ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE is acetaminophen; caffeine; dihydrocodeine bitartrate. There are sixty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE?
- What are the global sales for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE?
- What is Average Wholesale Price for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE?
Summary for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE at DailyMed |
US Patents and Regulatory Information for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Larken Labs Inc | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | acetaminophen; caffeine; dihydrocodeine bitartrate | TABLET;ORAL | 204209-001 | Sep 30, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
